HK23784A - Lactobacillus casei yit 9018 for use as an antitumour agent - Google Patents

Lactobacillus casei yit 9018 for use as an antitumour agent

Info

Publication number
HK23784A
HK23784A HK237/84A HK23784A HK23784A HK 23784 A HK23784 A HK 23784A HK 237/84 A HK237/84 A HK 237/84A HK 23784 A HK23784 A HK 23784A HK 23784 A HK23784 A HK 23784A
Authority
HK
Hong Kong
Prior art keywords
lactobacillus casei
casei yit
antitumour agent
yit
agent
Prior art date
Application number
HK237/84A
Other languages
English (en)
Inventor
Mutai Masahiko
Kobayashi Seizaburo
Yokokura Teruo
Kato Ikuo
Original Assignee
Kabushiki Kaisha Yakult Honsha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabushiki Kaisha Yakult Honsha filed Critical Kabushiki Kaisha Yakult Honsha
Publication of HK23784A publication Critical patent/HK23784A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK237/84A 1979-02-27 1984-03-15 Lactobacillus casei yit 9018 for use as an antitumour agent HK23784A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent

Publications (1)

Publication Number Publication Date
HK23784A true HK23784A (en) 1984-03-23

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
HK237/84A HK23784A (en) 1979-02-27 1984-03-15 Lactobacillus casei yit 9018 for use as an antitumour agent

Country Status (12)

Country Link
US (1) US4347240A (OSRAM)
JP (1) JPS55113718A (OSRAM)
BR (1) BR8001129A (OSRAM)
CA (1) CA1124176A (OSRAM)
CH (1) CH653556A5 (OSRAM)
DE (1) DE3007412A1 (OSRAM)
FR (1) FR2450108B1 (OSRAM)
HK (1) HK23784A (OSRAM)
IT (1) IT1129802B (OSRAM)
MY (1) MY8500010A (OSRAM)
NL (1) NL189999C (OSRAM)
SG (1) SG38183G (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus casei subsp casei 37 de production d'une preparation biologique bacterienne
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
WO1997049820A1 (en) 1996-06-26 1997-12-31 Kabushiki Kaisha Yakult Honsha Methods for transferring gene into chromosome
AU748744B2 (en) * 1997-02-11 2002-06-13 Enterprise Ireland Trading As Bioresearch Ireland Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
JP4678896B2 (ja) * 1997-04-18 2011-04-27 ガネデン バイオテック，インコーポレイテッド 微生物感染を予防または制御するための共生Ｂａｃｉｌｌｕｓ芽胞の局所的使用
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
WO2005000222A2 (en) * 2003-05-30 2005-01-06 Amylin Pharmaceuticals, Inc. Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
BRPI0413008B8 (pt) * 2003-07-30 2021-05-25 Bhph Company Ltd preparação de lactobacilos tendo uma espécie de lactobacillus casei ferm bp-10059 (ferm p-19443) e agente preventivo ou terapêutico contra infecções em humanos, animais e plantas tendo uma espécie de lactobacillus casei ferm bp-10059 (ferm p-19443)
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
DK1853284T3 (da) * 2005-02-11 2014-07-14 Biolactis Inc Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum
JPWO2008053588A1 (ja) * 2006-10-27 2010-02-25 株式会社ヤクルト本社 サイトカイン産生調節遺伝子及びその利用
WO2008053728A1 (en) * 2006-11-02 2008-05-08 Aureo Co., Ltd. Agent for promoting healing of living body
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
CN103037875B (zh) 2009-11-11 2014-11-05 食物营养健康有限公司 双歧杆菌菌株
AU2010317422A1 (en) 2009-11-11 2012-05-31 Alimentary Health Limited Probiotic Bifidobacterium strain
US11590179B2 (en) 2017-02-28 2023-02-28 Precisionbiotics Group Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
US11813297B2 (en) 2017-03-23 2023-11-14 Katholieke Universiteit Leuven, Ku Leuven R & D Probiotic Lactobacillus casei strain and its uses
US20230106819A1 (en) 2020-03-13 2023-04-06 Precisionbiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Also Published As

Publication number Publication date
FR2450108A1 (fr) 1980-09-26
NL189999B (nl) 1993-05-03
JPS55113718A (en) 1980-09-02
US4347240A (en) 1982-08-31
DE3007412A1 (de) 1980-11-06
IT8067302A0 (it) 1980-02-27
BR8001129A (pt) 1980-11-04
NL189999C (nl) 1993-10-01
CA1124176A (en) 1982-05-25
NL8001045A (nl) 1980-08-29
CH653556A5 (de) 1986-01-15
MY8500010A (en) 1985-12-31
JPS6234727B2 (OSRAM) 1987-07-28
IT1129802B (it) 1986-06-11
FR2450108B1 (fr) 1988-10-28
SG38183G (en) 1984-07-20

Similar Documents

Publication Publication Date Title
HK23784A (en) Lactobacillus casei yit 9018 for use as an antitumour agent
EP0453560A4 (en) Localization and characterization of the wilms's tumor gene
EP0246281A4 (en) MICROBIAL COMPOSITIONS AND METHOD FOR TREATING EARTH.
ZA805791B (en) Treatment method using the lh-rh or agonists
AU518629B2 (en) Stereotactic surgery apparatus and method
NO175042C (OSRAM)
ES8801546A1 (es) Un procedimiento para la preparacion de compuesto de 2,2-difluoronucleosidos.
AU1736088A (en) Methods of treating tumors with compositions of catecholic butanes
MW3080A1 (en) Preparations for the treatment of theileriosis and their use
CA2045594A1 (en) Immunogenic compositions against gastrin peptides
AU528025B2 (en) Equipment for the treatment of wet solids
AU3400297A (en) Gm-csf administration for the treatment and prevention of recurrence of brain tumors
CA2186851A1 (en) Use of mycobacteria for the treatment of tumours
AU6786887A (en) Tumor localization and therapy
DE3069952D1 (en) Dispersions of graft polymers, their preparation and use
DE3070082D1 (en) Dispersions of cografted polymers, process for their preparation and their use
AU8681482A (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infectious deseases of different types with the preparative use of alkaloid-compounds or their salts
CA2044421A1 (en) Squamous cell carcinoma-like immunoreactive antigen from human female urine
ZA954984B (en) Compositions and methods for the treatment of tumors
EG12644A (en) Process for the preparation of 3-4 dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1,dioxide and its use as intermadiate
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
AU6008180A (en) Derivatives of 1,1,1-trichloro-3-hydroxy-3-phenyl butane and treatment of soil
AU7770991A (en) Method and composition for the treatment of cancer
ZA9291B (en) Process for the detection and localization of cancer
IL99705A0 (en) Inhibitors for the formation of tumor necrosis factor,processes for the preparation thereof and the use thereof

Legal Events

Date Code Title Description
PE Patent expired